Phathom Pharmaceuticals, Inc.

UBS Group AG PHAT

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

304,383

Value ($000)

5,050

Weight

0.0%

2019 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	5,050	0.0%	304,383	12/31/2025
2025 Q3	11/13/2025	3,982	0.0%	338,360	9/30/2025
2025 Q2	8/14/2025	4,023	0.0%	419,473	6/30/2025
2025 Q1	5/13/2025	4,437	0.0%	707,578	3/31/2025
2024 Q4	2/14/2025	3,781	0.0%	465,616	12/31/2024
2024 Q3	11/14/2024	1,301	0.0%	71,941	9/30/2024
2024 Q2	8/14/2024	444	0.0%	43,086	6/30/2024
2024 Q1	5/13/2024	530	0.0%	49,923	3/31/2024
2023 Q4	2/9/2024	360	0.0%	39,432	12/31/2023
2023 Q3	11/9/2023	349	0.0%	33,700	9/30/2023
2023 Q2	8/11/2023	241	0.0%	16,806	6/30/2023
2022 Q4	2/8/2023	9	0.0%	795	12/31/2022
2022 Q3	11/10/2022	7	0.0%	628	9/30/2022
2021 Q4	2/14/2022	26	0.0%	1,329	12/31/2021
2021 Q2	8/13/2021	24	0.0%	699	6/30/2021
2021 Q1	5/12/2021	108	0.0%	2,877	3/31/2021
2020 Q4	2/11/2021	88	0.0%	2,657	12/31/2020
2020 Q3	11/12/2020	50	0.0%	1,374	9/30/2020
2020 Q2	7/31/2020	137	0.0%	4,177	6/30/2020
2020 Q1	5/1/2020	166	0.0%	6,415	3/31/2020
2019 Q4	2/14/2020	439	0.0%	14,099	12/31/2019